Szemészet, 2015 (152. évfolyam, 1-4. szám)

2015-03-01 / 1. szám

Clinical forms and treatment of herpetic keratitis

Irodalom

1. Bacon TH, Levin MJ, Leary JJ, et a I. Herpes simplex virus resitance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev 2003; 16: 114-128.

2. Cockerham GC, Krafft AE, McLean IW. Herpes simplex virus in primary graft failure. Arch Ophthalmol 1197; 115: 586-589.

3. Collum LMT, Benedict-Smith A, Hillary IB. Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration. Br J Ophthalmol 1980; 64: 766-769.

4. Cook SD, Hill HJ. Herpes simplex virus: molecular biology and the possibility of corneal latency. Surv Ophthalmol 1991; 36: 140-14.

5. Cursiefen C, Colin J, Dana R, et al. Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable. Br J Ophthalmol 2012; 96: 3-9.

6. De Groot-Mijnes JD, Rothova A, Van Loon AM, et al. Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis. Am J Ophthalmol 2006; 141: 313-318.

7. Duan R, Vries RD, de Dun JM van, et al. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis. J Infect Dis 2009; 1402-1414.

8. Faulds D, Goa KL, Benfield P Cyclosporin. A review of its pharmacodynamic and pharmacokinatical properties, and therapeutic use in immunoregulatory disorders. Drugs 1991; 32: 953-1040.

9. Gordon YJ, Romanowski E, Araullo T, Cruz Mcknight JLC. HSV-1 corneal latency. Invest Ophthalmol Vis Sei 1991; 237: 435-438.

10. Heiligenhaus A, Steuhl KP Topical cyclosporin A in patients with herpes simplex stromal keratitis. Graefes Arch Clin Exp Ophthalmol 2001;42:1969-1974

11. Heiligenhaus A, Bauer D, Meller D. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. Invest Ophtahlmol Vis Sei 2001; 42: 1969-1974.

12. Heiligenhaus A, Li H, Hernandez Galindo EE, et al. Management of acute ulcerative and necrotizing herpes simplex and zooster keratitis with amniotic membrane transplantation. Br J Ophthalmol 2003; 87: 1215-1219.

13. Hoh HB, Goldschmidt P Easty DL. Comparative efficacy of ganciclovir and acyclovir ointment int he treatment of herpes siplex dendritic keratitis. Curr Eye Res 1992; 101: 68-72.

14. Holbach LM, Asano N, Naumann GO. Infection of the corneal endothelium in herpes simplex keratitis. Am J Ophthalmol 1998; 126: 592-594.

15. Holbach LM. Font RL, Naumann GO. Herpes simplex stromal and endothelial keratitis. Ophthalmology 1990; 97: 722-728.

16. Holland EJ, Schwartz GS. Classification of herpes simplex virus keratitis. Cornea 1999; 18: 144-154.

17. Liesegang TJ. Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 1989; 107:1160-1165.

18. Liesegang TJ. Classification of herpes simplex virus keratitis and anterior uveittis. Cornea 1999; 18: 127-143.

19. Naumann GO, Gass J, Font R. Histopathology of herpes zoster ophthalmicus. Am J Ophthalmol 1968; 65: 533-541.

20. Tektas OY, Heinz C, Heiligenhaus A, et al. Morphological changes in trabeculectomy specimen sin different kinds of uveitis glaucoma. Curr Eye Res 2011; 36: 442-8.

21. Power WJ, Benedict-Smith A, Hillery M, et al. Randomised doubleblind trial of bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration. Br J Ophthalmol 1991; 75: 649-651.

22. Rao SN. Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%. Am J Ophthalmol 2006; 141: 771-772.

23. Remeijer L, Duan R, Dun JM van, et a I. Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues. J Infect Dis 2009; 200: 11—19.

24. Remeijer L, Osterhaus ADME, Verjans GMGM. Human herpes simplex virus keratitis: the pathogenesis revisited. Ocular Immunol Inflamm 2004;12: 255-285.

25. Roizman B, Knipe DM, Whitley RJ. herpes simplex virus. In: Knipe DM, Howley PM (Hrsg). Fields virology, 5. Aufl. Lippincott Williams & Wilkins, Philadelphia, S 2502-2507.

26. Saravia M, Zapata G, Ferraiolo R et al. Anti-VEGF monoclonal antibody-induced regression of corneal neovascularisation and inflammation in a rabbit model of herpetic stromal keratitis. Graefes Arch Clin Exp Ophthalmol 2009; 247: 1409-1416.

27. Schacher S, Garwg JG, Russ C, et al. Die Diagnostic of herpetic keratitis and keratouveitis. Klin Monatsbl Augenhilkd 1998; 102: 15-26.

28. Seitz B, Grütereich M, Cursiefen C, Kruse FE. Conservative and surgical therapy of neurotrophic keratopathy. Ophthalmologe 2005; 102:15-26.

29. Seitz B, Resch MD, Schlötzer-Schrehardt U, et al. Histopathology and ultrastructure of human corneas after amniotic membrane transplantation. Arch Ophthalmol 2006; 124: 1487-1490.

30. Sengler U, Reinhard T, Adams 0. et al. Herpes simplex virus infection in the media of donor corneas during organ culture: frequency and consequences. Eye 2001; 15: 644-S47.

31. Sheridan BS, Knickelbein JE, Hendricks RL. CD8T cells and latent herpes simplex virus type 1: keeping the peace in sensory ganglia. Expert Opin Biol Ther 2007; 7: 1323-1331.

32. Sundmacher R, Neumann-Haefelein D. Herpes simplex virus isolation from the aqueous of patients suffering from focal iritis, endotheliitis, and prolonged disciform keratitis with glaucoma. Klin Monatsbl Augenheilkd 1979; 175: 488-501.

33. Sundmacher R. A clinico-virologic classification of herpetic anteripr segment disease with special reference to intraocular herpes. In: Sunmacher R (Hrsg.) Herpetische Augenerkrankungen. München: Bergmann; 1981. S203.

34. Sundmacher R. Therapie der herpetischen Erkrankungen des vorderen Augenabschnitts. Klin MOnatsbl Augenheilkd 1985; 186: 421-423.

35. Sundmacher R. Color atlas of herpetic eye disease. Berlin, Heidelberg: Springer; 2009.

36. The Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The Epithelial keratitis trial. Arch Ophthalmol 1997; 115: 703-712.

37. The Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 1998; 339: 300-306.

38. The Herpetic Eye Disease Study Group. Psychological stress and other potential triggers for the recurrence of herpes simplex virus eye infections. Arch Ophthalmol 2000; 118: 1617-1625.

39. The Herpetic Eye Disease Study Group. Predictors of recurrent herpes simplex virus keratitis. Cornea 2001; 20: 123-128

40. Van der Lelij A, Ooijman FM, Kijlstra A, Rothova A. Anteror Uveitis with sectorial iris atrophy in the absence of keratitis: a distinct clinical entity among herpetic eye diseased. Ophthalmology 2000; 107:1164-1170.

41. Rooij J van, Rijneveld WJ, Remeijer L, et al. Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis. A placebo-controlled multicenter trial. Ophthalmology 2003; 110: 1916-1919.

42. Seitz B, Heiligenhaus A. Herpetic keratitis. Various expressions require different therapeutic approaches. Ophthalmology 2011; 108: 385-398.

43. Zierhut M, Ziemssen F Bodahgi B. Augenbeteiligungen bei HSV-lnfektion. In: Zierhut M, Hansen L, Jahn G (Hrsg) Viruserkrankungen des Auges. Heidelberg Kaden: 2007. S50-65.

44. Süveges I, Füst Á, Imre L. Postoperative therapy after penetrating keratoplasty in herpes simplpex keratitis. Orv Hetil 2013; 154: 2065-70.

Levelezési cím

Dn Szentmáry Nóra, 1085 Budapest, Mária utca 39. E-mail: nszentmary@hotmail.com